Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerald Brosch is active.

Publication


Featured researches published by Gerald Brosch.


Molecular and Cellular Biology | 1999

Histone Deacetylase 1 Can Repress Transcription by Binding to Sp1

Angelika Doetzlhofer; Hans Rotheneder; Gerda Lagger; Manfred Koranda; Vladislav Kurtev; Gerald Brosch; Erhard Wintersberger; Christian Seiser

ABSTRACT The members of the Sp1 transcription factor family can act as both negative and positive regulators of gene expression. Here we show that Sp1 can be a target for histone deacetylase 1 (HDAC1)-mediated transcriptional repression. The histone deacetylase inhibitor trichostatin A activates the chromosomally integrated murine thymidine kinase promoter in an Sp1-dependent manner. Coimmunoprecipitation experiments with Swiss 3T3 fibroblasts and 293 cells demonstrate that Sp1 and HDAC1 can be part of the same complex. The interaction between Sp1 and HDAC1 is direct and requires the carboxy-terminal domain of Sp1. Previously we have shown that the C terminus of Sp1 is necessary for the interaction with the transcription factor E2F1 (J. Karlseder, H. Rotheneder, and E. Wintersberger, Mol. Cell. Biol. 16:1659–1667, 1996). Coexpression of E2F1 interferes with HDAC1 binding to Sp1 and abolishes Sp1-mediated transcriptional repression. Our results indicate that one component of Sp1-dependent gene regulation involves competition between the transcriptional repressor HDAC1 and the transactivating factor E2F1.


Cancer Research | 2005

Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas

Keith W. Vance; Suzanne Carreira; Gerald Brosch; Colin R. Goding

The INK4a and ARF genes found at the CDKN2A locus are key effectors of cellular senescence that is believed to act as a powerful anticancer mechanism. Accordingly, mutations in these genes are present in a wide variety of spontaneous human cancers and CDKN2A germ line mutations are found in familial melanoma. The TBX2 gene encoding a key developmental transcription factor is amplified in pancreatic cancer cell lines and preferentially amplified and overexpressed in BRCA1 and BRCA2 mutated breast tumors. Overexpression of Tbx2 and the related factor Tbx3, which is also overexpressed in breast cancer and melanomas, can suppress senescence in defined experimental systems through repression of ARF expression. However, it is not known how Tbx2 mediates its repressive effect nor whether endogenous Tbx2 or Tbx3 perform a similar antisenescence function in transformed cells. This is a particularly important question because the loss of CDKN2A in many human cancers would, in principle, bypass the requirement for Tbx2/3-mediated repression of ARF in suppressing senescence. We show here that Tbx2 is overexpressed in melanoma cell lines and that Tbx2 targets histone deacetylase 1 to the p21Cip1 (CDKN1A) initiator. Strikingly, expression of an inducible dominant-negative Tbx2 (dnTbx2) leads to displacement of histone deacetylase 1, up-regulation of p21(Cip1) expression, and the induction of replicative senescence in CDKN2A-null B16 melanoma cells. In human melanoma cells, expression of dnTbx2 leads to severely reduced growth and induction of senescence-associated heterochromatin foci. The results suggest that the activity of endogenous Tbx2 is critically required to maintain proliferation and suppress senescence in melanomas.


The Plant Cell | 1995

Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum.

Gerald Brosch; Richard Ransom; Thomas Lechner; Jonathan D. Walton; Peter Loidl

HC toxin, the host-selective toxin of the maize pathogen Cochliobolus carbonum, inhibited maize histone deacetylase (HD) at 2 microM. Chlamydocin, a related cyclic tetrapeptide, also inhibited HD activity. The toxins did not affect histone acetyltransferases. After partial purification of histone deacetylases HD1-A, HD1-B, and HD2 from germinating maize embryos, we demonstrated that the different enzymes were similarly inhibited by the toxins. Inhibitory activities were reversibly eliminated by treating toxins with 2-mercaptoethanol, presumably by modifying the carbonyl group of the epoxide-containing amino acid Aeo (2-amino-9,10-epoxy-8-oxodecanoic acid). Kinetic studies revealed that inhibition of HD was of the uncompetitive type and reversible. HC toxin, in which the epoxide group had been hydrolyzed, completely lost its inhibitory activity; when the carbonyl group of Aeo had been reduced to the corresponding alcohol, the modified toxin was less active than native toxin. In vivo treatment of embryos with HC toxin caused the accumulation of highly acetylated histone H4 subspecies and elevated acetate incorporation into H4 in susceptible-genotype embryos but not in the resistant genotype. HDs from chicken and the myxomycete Physarum polycephalum were also inhibited, indicating that the host selectivity of HC toxin is not determined by its inhibitory effect on HD. Consistent with these results, we propose a model in which HC toxin promotes the establishment of pathogenic compatibility between C. carbonum and maize by interfering with reversible histone acetylation, which is implicated in the control of fundamental cellular processes, such as chromatin structure, cell cycle progression, and gene expression.


Journal of Medicinal Chemistry | 2008

epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.

Antonello Mai; Donghang Cheng; Mark T. Bedford; Sergio Valente; Angela Nebbioso; Andrea Perrone; Gerald Brosch; Gianluca Sbardella; Floriana De Bellis; Marco Miceli; Lucia Altucci

A number of new compounds bearing two ortho-bromo- and ortho, ortho-dibromophenol moieties linked through a saturated/unsaturated, linear/(poly)cyclic spacer (compounds 1- 9) were prepared as simplified analogues of AMI-5 (eosin), a recently reported inhibitor of both protein arginine and histone lysine methyltransferases (PRMTs and HKMTs). Such compounds were tested against a panel of PRMTs (RmtA, PRMT1, and CARM1) and against human SET7 (a HKMT), using histone and nonhistone proteins as a substrate. They were also screened against HAT and SIRTs, because they are structurally related to some HAT and/or SIRT modulators. From the inhibitory data, some of tested compounds ( 1b, 1c, 4b, 4f, 4j, 4l, 7b, and 7f) were able to inhibit PRMTs, HKMT, HAT, and SIRTs with similar potency, thus behaving as multiple ligands for these epigenetic targets (epi-MLs). When tested on the human leukemia U937 cell line, the epi-MLs induced high apoptosis levels [i.e., 40.7% ( 4l) and 42.6% ( 7b)] and/or massive, dose-dependent cytodifferentiation [i.e., 95.2% ( 1c) and 96.1% ( 4j)], whereas the single-target inhibitors eosin, curcumin, and sirtinol were ineffective or showed a weak effect.


The EMBO Journal | 1998

The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Anton Bauer; Wolfgang Mikulits; Gerda Lagger; Gabi Stengl; Gerald Brosch; Hartmut Beug

The avian erythroblastosis virus (AEV) oncoprotein v‐ErbA represents a mutated, oncogenic thyroid hormone receptor α (c‐ErbA/ TRα). v‐ErbA cooperates with the stem cell factor‐activated, endogenous receptor tyrosine kinase c‐Kit to induce self‐renewal and to arrest differentiation of primary avian erythroblasts, the AEV transformation target cells. In this cooperation, v‐ErbA substitutes for endogenous steroid hormone receptor function required for sustained proliferation of non‐transformed erythroid progenitors. In this paper, we propose a novel concept of how v‐ErbA transforms erythroblasts. Using culture media strictly depleted from thyroid hormone (T3) and retinoids, the ligands for c‐ErbA/TRα and its co‐receptor RXR, we show that overexpressed, unliganded c‐ErbA/ TRα closely resembles v‐ErbA in its activity on primary erythroblasts. In cooperation with ligand‐activated c‐Kit, c‐ErbA/ TRα causes steroid‐independent, long‐term proliferation and tightly blocks differentiation. Activation of c‐ErbA/ TRα by physiological T3 levels causes the loss of self‐renewal capacity and induces synchronous, terminal differentiation under otherwise identical conditions. This T3‐induced switch in erythroid progenitor development is correlated with a decrease of c‐ErbA‐associated histone deacetylase activity. Our results suggest that the crucial role of the mutations activating v‐erbA as an oncogene is to ‘freeze’ c‐ErbA/ TRα in its non‐liganded, repressive conformation and to facilitate its overexpression.


Fems Microbiology Reviews | 2008

Histone modifications and chromatin dynamics: a focus on filamentous fungi.

Gerald Brosch; Peter Loidl; Stefan Graessle

The readout of the genetic information of eukaryotic organisms is significantly regulated by modifications of DNA and chromatin proteins. Chromatin alterations induce genome-wide and local changes in gene expression and affect a variety of processes in response to internal and external signals during growth, differentiation, development, in metabolic processes, diseases, and abiotic and biotic stresses. This review aims at summarizing the roles of histone H1 and the acetylation and methylation of histones in filamentous fungi and links this knowledge to the huge body of data from other systems. Filamentous fungi show a wide range of morphologies and have developed a complex network of genes that enables them to use a great variety of substrates. This fact, together with the possibility of simple and quick genetic manipulation, highlights these organisms as model systems for the investigation of gene regulation. However, little is still known about regulation at the chromatin level in filamentous fungi. Understanding the role of chromatin in transcriptional regulation would be of utmost importance with respect to the impact of filamentous fungi in human diseases and agriculture. The synthesis of compounds (antibiotics, immunosuppressants, toxins, and compounds with adverse effects) is also likely to be regulated at the chromatin level.


Bioorganic & Medicinal Chemistry Letters | 1997

Analogues of trichosтatin a and trapoxin B as histone deacetylase inhibitors

Manfred Jung; Katharina Hoffmann; Gerald Brosch; Peter Loidl

Abstract Inhibitors of histone deacetylase are potent inducers of differentiation and bear considerable potential as drugs for chemoprevention and treatment of cancer. So far only complex natural products and a few synthetic congeners have been identified as specific inhibitors. We have prepared a set of simple analogues in as little as four synthetic steps that have inhibitory potencies in the range of known cyclotetrapeptide inhibitors. These compounds are interesting leads for the design of potent inhibitors of histone deacetylase.


Planta | 2001

Comparative analysis of HD2 type histone deacetylases in higher plants

Markus Dangl; Gerald Brosch; Hubertus Haas; Peter Loidl; Alexandra Lusser

Abstract. Zea mays (L.) histone deacetylase HD2 was identified as a new type of histone deacetylase (HDAC) unrelated to the well-known Rpd3p and Hda1p families but with sequence homology to peptidyl-prolyl cis-trans isomerases (PPIases). Here we show that HD2 is a multigene family with highly related members in various plant species. Gene analysis revealed a similar exon/intron structure in Arabidopsis thaliana (L.) Heynh. and Z. mays, and most of the sequences analyzed were demonstrated to possess an intron of the very rare AT-AC type.


Biochimica et Biophysica Acta | 1996

A COMPARATIVE STUDY OF HISTONE DEACETYLASES OF PLANT, FUNGAL AND VERTEBRATE CELLS

Thomas Lechner; Alexandra Lusser; Gerald Brosch; Anton Eberharter; Maria Goralik-Schramel; Peter Loidl

The enzymatic equilibrium of reversible core histone acetylation is maintained by two enzyme activities, histone acetyltransferase and histone deacetylase (HD). These enzyme activities exist as multiple enzyme forms. The present report describes methods to extract different HD-forms from three organisms, germinating maize embryos, the myxomycete Physarum polycephalum, and chicken red blood cells; it provides data on the chromatographic separation and partial purification of HD-forms. In germinating maize embryos three HDs (HD1-A, HD1-B, HD2) can be discriminated; HD1-A, HD1-B, and HD2 were characterized in terms of their dependence on pH, temperature and various ions, as well as kinetic parameters (Km for core histones) and inhibition by various compounds. The same parameters were investigated for the corresponding enzymes of Physarum polycephalum, and mature and immature chicken erythrocytes. Based on these results, optimum assay conditions were established for the different enzyme forms. The kinetic data revealed that the maize histone deacetylase HD1-B peak after partial purification by Q-Sepharose chromatography was heterogeneous and consisted of two histone binding sites that differed significantly in their affinity for purified core histones. Optimized affinity chromatography on poly-Lysine Agarose indeed showed that the former defined deacetylase HD1-B can be separated clearly into two individual HD enzyme forms. The high multiplicity of histone deacetylases underlines the importance of these enzymes for the complex regulation of core histone acetylation.


FEBS Letters | 1993

Histone deacetylase: A key enzyme for the binding of regulatory proteins to chromatin

Gerardo López-Rodas; Gerald Brosch; Elena I. Georgieva; Ramon Sendra; Luis Franco; Peter Loidl

Core histones can be modified by reversible, posttranslational acetylation of specific lysine residues within the N‐terminal protein domains. The dynamic equilibrium of acetylation is maintained by two enzyme activities, histone acetyltransferase and histone deacetylase. Recent data on histone deacetylases and on anionic motifs in chromatin‐ or DNA‐binding regulatory proteins (e.g. transcription factors, nuclear proto‐oncogenes) are summarized and united into a hypothesis which attributes a key function to histone deacetylation for the binding of regulatory proteins to chromatin by a transient, specific local increase of the positive charge in the N‐terminal domains of nucleosomal core histones. According to our model, the rapid deacetylation of distinct lysines in especially H2A and H2B would facilitate the association of anionic protein domains of regulatory proteins to specific nucleosomes. Therefore histone deacetylation (histone deacetylases) may represent a unique regulatory mechanism in the early steps of gene activation, in contrast to the more structural role of histone acetylation (histone acetyltransferases) for nucleosomal transitions during the actual transcription process.

Collaboration


Dive into the Gerald Brosch's collaboration.

Top Co-Authors

Avatar

Peter Loidl

University of Innsbruck

View shared research outputs
Top Co-Authors

Avatar

Antonello Mai

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rino Ragno

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Patrick Trojer

University of Medicine and Dentistry of New Jersey

View shared research outputs
Top Co-Authors

Avatar

Ingo Bauer

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Angela Nebbioso

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors

Avatar

Lucia Altucci

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors

Avatar

Silvia Simeoni

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge